KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) EBITDA (2016 - 2025)

Encompass Health (EHC) has disclosed EBITDA for 17 consecutive years, with -$264.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 238.95% year-over-year to -$264.7 million, compared with a TTM value of $111.1 million through Dec 2025, down 81.38%, and an annual FY2025 reading of $438.3 million, down 26.53% over the prior year.
  • EBITDA was -$264.7 million for Q4 2025 at Encompass Health, down from $179.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $190.5 million in Q4 2024 and bottomed at -$264.7 million in Q4 2025.
  • Average EBITDA over 5 years is $96.5 million, with a median of $111.3 million recorded in 2022.
  • The sharpest move saw EBITDA skyrocketed 323.88% in 2021, then crashed 238.95% in 2025.
  • Year by year, EBITDA stood at $115.7 million in 2021, then decreased by 22.73% to $89.4 million in 2022, then surged by 90.72% to $170.5 million in 2023, then increased by 11.73% to $190.5 million in 2024, then plummeted by 238.95% to -$264.7 million in 2025.
  • Business Quant data shows EBITDA for EHC at -$264.7 million in Q4 2025, $179.0 million in Q3 2025, and $45.3 million in Q2 2025.